Latest Breaking News On - Institutional investors weigh in on amphastar pharmaceuticals - Page 1 : comparemela.com

Amphastar Pharmaceuticals (NASDAQ:AMPH) Upgraded at StockNews com

Amphastar Pharmaceuticals (NASDAQ:AMPH) Upgraded at StockNews com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Los angelesUnited statesMichaela zasloffExchange traded conceptsSecurities exchange commissionAmphastar pharmaceuticals incAmphastar pharmaceuticalsNews ratings for amphastar pharmaceuticals dailyBridge city capitalLos angeles capital managementNeedham companyQuadrant capital groupAmphastar pharmaceuticals tradingAmphastar pharmaceuticals company profileJpmorgan chase coInstitutional investors weigh in on amphastar pharmaceuticals

Amphastar Pharmaceuticals, Inc (NASDAQ:AMPH) Director Sells $21,715 00 in Stock

Amphastar Pharmaceuticals, Inc (NASDAQ:AMPH) Director Sells $21,715 00 in Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesFloydf petersenMcglone suttner wealth management incJpmorgan chase coAmphastar pharmaceuticals trading downNews ratings for amphastar pharmaceuticals dailyPrincipal securities incAmphastar pharmaceuticals incQuarter for amphastar pharmaceuticalsTower groupInstitutional investors weigh in on amphastar pharmaceuticalsRonald blue trust incAmphastar pharmaceuticalsGet free reportDirector floydPharmaceuticals trading down

Amphastar Pharmaceuticals (NASDAQ:AMPH) Raised to Buy at StockNews com

Amphastar Pharmaceuticals (NASDAQ:AMPH) Raised to Buy at StockNews com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesRichardk prinsFloydf petersenPrincipal securities incTower groupAmphastar pharmaceuticalsAmphastar pharmaceuticals incAmphastar pharmaceuticals tradingMcglone suttner wealth management incAmphastar pharmaceuticals company profileRonald blue trust incInstitutional investors weigh in on amphastar pharmaceuticalsNews ratings for amphastar pharmaceuticals dailyFree reportGet free reportDirector richard

Amphastar Pharmaceuticals (NASDAQ:AMPH) Upgraded by StockNews com to Buy

StockNews.com upgraded shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) from a hold rating to a buy rating in a report released on Friday morning. Separately, Bank of America started coverage on shares of Amphastar Pharmaceuticals in a research report on Friday, November 17th. They issued a neutral rating and a $63.00 price target for […]

United statesRichardk prinsAmphastar pharmaceuticals price performanceNews ratings for amphastar pharmaceuticals dailyRonald blue trust incInstitutional investors weigh in on amphastar pharmaceuticalsChina universal asset management coAmphastar pharmaceuticals incTower groupAmphastar pharmaceuticalsPacer advisors incFree reportGet free reportDirector richardBlue trustUniversal asset management

Amphastar Pharmaceuticals (NASDAQ:AMPH) Lifted to Buy at StockNews com

StockNews.com upgraded shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) from a hold rating to a buy rating in a research note released on Friday morning. Separately, Bank of America started coverage on Amphastar Pharmaceuticals in a research note on Friday, November 17th. They issued a neutral rating and a $63.00 price objective on the […]

United statesRichardk prinsFloydf petersenAmphastar pharmaceuticals incAmphastar pharmaceuticals trading downPacer advisors incAmphastar pharmaceuticalsTower groupInstitutional investors weigh in on amphastar pharmaceuticalsChina universal asset management coSecurities exchange commissionRonald blue trust incInsider activity at amphastar pharmaceuticalsNews ratings for amphastar pharmaceuticals dailyAmphastar pharmaceuticals company profileFree report